As of 1:31 PM on the 29th, IQVIA is trading at 42,050 KRW, down 4.97% from the previous day. This represents a 34.19% decline compared to June 24. IQVIA is known as a company possessing core technology for transdermal drug delivery systems.
Over the past 5 days, individual investors have net purchased 215,846 shares, while foreign investors and institutions have net sold 49,474 shares and 144,240 shares, respectively.
On June 25, IQVIA became a market issue with the headline "Did the positive news of joint development with Celltrion fade? Sudden plunge."
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
